TP-04-HN-106

N/A

Report date: 2026/05/10 20:00:19
NME

Base Information

Drug NameTP-04-HN-106
Drug Alias NameTP04HN106TP-04-HN-106
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesTalengen Inst Life Sciences Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTalengen Inst Life Sciences Co Ltd
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A